Sofinnova Venture Partners X, L.P. - Feb 6, 2023 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
10%+ Owner
Signature
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P.
Stock symbol
VERA
Transactions as of
Feb 6, 2023
Transactions value $
$1,999,998
Form type
4
Date filed
2/8/2023, 05:29 PM
Previous filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $2M +286K +8.98% $7.00 3.47M Feb 6, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares are held directly by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.P. ("SM X LP") is the general partner of SVP X and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. Sofinnova Management X-A, L.L.C. ("SM X LLC") is the general partner of SVP X LP and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by SVP X. James I. Healy and Maha Katabi are the managing members of SM X LLC and may be deemed to have shared voting, investment and dispositive power with respect to the shares held by SVP X. Each of the Reporting Persons disclaims beneficial ownership of such securities, except to the extent of his, her or its proportionate pecuniary interest therein.